The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0855
Bid: 0.085
Ask: 0.086
Change: -0.0075 (-8.11%)
Spread: 0.001 (1.176%)
Open: 0.0925
High: 0.095
Low: 0.085
Prev. Close: 0.0925
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Audited results for the year ended 30 June 2023

29 Sep 2023 07:00

RNS Number : 0786O
CAP-XX Limited
29 September 2023
 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

 

29 September 2023

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Audited results for the year ended 30 June 2023

 

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors and energy management systems, is pleased to announce its audited results for the year ended 30 June 2023.

 

 

Key highlights

 

· Product sales and total revenue down 35% on last year

 

· Gross margin of 43% broadly in line with last year

 

· Adjusted EBITDA loss* of A$1.3 million, is up on the previous year (A$0.5 million) primarily due to the costs associated with the change in CEO.

 

· Outstanding committed order backlog up by 75% on the same time last year

 

· Pipeline of new products and services to meet the changing customer requirements and enhance competitive market position

 

· CAP-XX continues to pursue patent infringement action against Maxwell Technologies (which is still a wholly owned subsidiary of Tesla Inc.) and other parties. Operating expenses were negatively impacted by A$1.5 million of associated legal expenditure, down A$1.0 million on prior year

 

· Royalty contribution is primarily from AVX, with court proceedings in place to ensure payments reflect what is properly owed

 

· CAP-XX cash reserves as at 30 June 2023 were A$2.6 million, which does not include a A$1.1 million revolving line of credit drawdown funded by a A$2.0 million R&D tax rebate which is due during H1 of FY2024

 

* Adjusted to exclude legal expenses for patent infringement ,CEO transition expenditure, bad debt provision and the amortisation of share-based payment expenses.

 

 

Electronic copies of CAP-XX's audited annual report and accounts for the year ended 30 June 2023 will shortly be available from the Company's website: www.cap-xx.com

 

The Company also announces that its Joint Broker has changed its name to Cavendish Securities plc following completion of its own corporate merger.

 

 

For further information contact:

 

CAP-XX Limited

Pat Elliott (Chairman)

Lars Stegmann (CEO)

 

+61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed

 

+44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance)

Tony Quirke/Stefano Aquilino (Sales and Corporate Broking)

 

+44 (0) 20 3328 5656

Cavendish Securities plc (Joint Broker)

Neil McDonald / Pearl Kellie

 

+44 (0) 13 1220 6939

 

More information is available at www.cap-xx.com

 

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

 

 

Chief Executive's review

 

There is no denying that these have been tough times for our organisation, and I want to acknowledge the hard work and dedication of our entire team in the face of adversity. The past few months have been marked by a volatile market, economic uncertainties and unprecedented challenges. We've seen our revenues decline, and our bottom line has been hit hard. It's not easy to stand before you and admit that we've faced difficulties, but it's important to recognise the reality of our situation.

 

However, I want to emphasise that even in these trying times, there is a silver lining. The challenges encountered have provided us with invaluable lessons and opportunities for growth. As a company, we've demonstrated resilience and adaptability in the face of adversity. Our team has come together, demonstrating an unwavering commitment to our mission and values.

 

While our results for the past few months may not be what we had hoped for, I want to assure you that we are well-positioned for a brighter future. We have a strategic plan in place that will help us navigate these turbulent waters and emerge stronger on the other side.

 

First and foremost, our commitment to innovation remains steadfast. We have a pipeline of exciting new products and services that are set to launch in the coming months. These innovations will not only meet the changing needs of our customers but also give us a competitive edge in the market.

 

Additionally, we are taking proactive measures to streamline our operations and optimise efficiency. This includes cost-saving initiatives that will help us weather the current economic challenges and position us for sustained profitability in the future.

 

Furthermore, we are actively diversifying our revenue streams and exploring new markets. We understand the importance of not relying solely on one segment of the market, especially in volatile times. Our expansion into new territories and industries is a strategic move that will mitigate risks and open up new growth opportunities.

 

One of our greatest assets is our dedicated and talented team. Our employees have shown incredible commitment and adaptability during these challenging times. We will continue to invest in their development and well-being, ensuring that we have the best talent driving our success.

 

In times like these, maintaining strong relationships with our partners, suppliers and customers is paramount. We are working closely with them to navigate the current market conditions, and these collaborations are critical to our future success. Together, we will find innovative solutions to the challenges we face.

 

While we cannot predict the exact timeline for a market recovery, we are confident that the positive trends we see on the horizon will lead to improved results in the coming months. We have a clear vision for the future, and we remain unwavering in our commitment to achieving our long-term goals.

 

In conclusion, I want to express my gratitude to all of our employees, shareholders, customers and partners, for your continued support and dedication. These are undoubtedly difficult times, but they are also times of great opportunity for growth and transformation. Together, we will emerge from this challenging period stronger, more resilient and better positioned for success, and we look forward to achieving great things together in the months and years ahead.

 

Lars Stegmann

 

Chief Executive Officer

 

 

Chairman's Report

 

The past year for CAP-XX has been one of major change and developments, which has established the company for short to medium term success. The major change is in the executive leadership of the Company with the appointment of Lars Stegmann as CEO, replacing CAP-XX's founder Anthony Kongats.

 

Lars brings to CAP-XX an extensive results and customer focussed background in power electronics and international sales and marketing. He has joined CAP-XX as we drive the expansion of our sales and distribution channels. This is the next step as the commissioning of the Seven Hills, Sydney manufacturing facility is largely completed and the plant operating efficiently, albeit with room for further improvement. The need now is to drive volumes to get the full benefit of this expansion and achieve profitable operations after many years of painful losses.

 

Another significant development was the completion of a capital raising of approximately £2.7 million, via a combination of a placing, subscription and retail offer. The fundraising was completed in two tranches and the final tranche completed in the first week of June 2023, the proceeds to be used for expansion of the current product range, increasing the sales and marketing footprint, litigation expenses, capital expenditure (predominately production equipment) and general working capital. We are grateful for the support of our shareholders through the provision of the necessary capital.

 

I am pleased to report that the development and broadening of the CAP-XX product range remains broadly on track, with the commissioning of the DMH production line at Seven Hills expected to deliver samples before the end of the current calendar year. We expect volumes to ramp up by early in the next calendar year. Several customers are in the latter stages of sampling these products for potentially high-volume applications, and feedback on customer evaluation is encouraging. The DMH product is a very thin (0.4 mm) supercapacitor suitable for numerous applications in IoT, Medical, Telecommunications and Industrial sectors.

 

In addition, the long-awaited 3V supercapacitor product is able to be produced in volume and is currently being evaluated by several potential large volume customers. These are anticipated to be realised in the second half of the current financial year.

 

Finally, the development work on the cylindrical surface mount device (SMD) is nearing completion with production trials underway. The SMD device offers customers supercapacitor performance in a form factor that is more suitable for many automated manufacturing assembly lines. These new products are expected to deliver significant sales gains as we achieve design wins over the coming year.

 

To ensure that we maximise the benefits of our existing product range and new products, we have also expanded our distribution network. Digikey was brought on as a distributor in April 2023 and to date has processed over 50 customer enquiries and sales. Numerous other Tier 1 and Tier 2 distributors are also in negotiation to stock the CAP-XX product range. To avoid further delays, we will continue to discuss with Tier 3 and Tier 4 distributors to expand our network and services.

 

As an integral part of our new distribution strategy, we are ensuring that the customer and their specific requirements are the core focus. The CAP-XX direct sales force is being expanded to ensure that a greater geographic reach is in place while CAP-XX representatives will have smaller regional territories, with a consummate increase in customer communication. To ensure that cash reserves are conserved, the additional sales representatives are being engaged on a commission basis. This has already resulted in driving short-term sales growth and early results are promising. New sales representatives are currently in place in the US (three), Europe, India and South Africa. Negotiations are in the final stages with several other representative organisations which will further expand the sales base.

 

Seven Hills production is currently operating on a single shift basis, which is matched with current demand and has the capacity to rapidly ramp production to meet the expected increase in demand. The successful commissioning of the new manufacturing lines has resulted in a lower cost of in-house production. An evaluation is underway to determine when the current Seven Hills product range can be expanded in order to reduce the risk of reliance on the contract manufacturer in Penang. During the year delayed COVID issues continued to impact the performance and output of the contract manufacturer in Penang. However, as the travel bans were lifted in the second half of the financial year, our engineers were again able to travel to support this facility. I am pleased to report that output continues to increase, although there is still more remedial work to be done to have this facility performing at historical levels.

 

CAP-XX continues to pursue a patent infringement action against Maxwell Technologies, a wholly owned subsidiary of Tesla Inc. As previously announced, due to the unavailability of expert witnesses for Maxwell, the trial date was deferred from July 2023 to December 2023. In September 2023, CAP-XX was advised that Tesla had lodged a patent infringement claim against CAP-XX for patent infringement in a Texas court. On the data and evidence lodged to date, CAP-XX is of the opinion that the claim is baseless and that it will be vigorously defended. CAP-XX remains in dispute with AVX over AVX's contractual performance in relation to the licence agreement granted by CAP-XX to AVX. The Company remains confident that positive outcomes will be reached in both cases in the current financial year.

 

Total Company sales revenue for the year to 30 June 2023 decreased by 35% to A$3.6 million (2022: A$5.6 million). The largest drop in sales revenue by product category was cylindrical cans which bore the full brunt of the supply chain issues during late 2022 and early 2023, while Seven Hills manufactured products were on par in both volume and dollars compared with the previous year. As reported at the half year, sales were being negatively impacted due mainly to worldwide supply chain issues and customers/distributors being over-stocked. It was also highlighted that it was too early to determine when the recovery would occur although the second half revenue was expected to be higher than the first. This was achieved, albeit at a lower rate than what was initially expected. Conversely, the fourth quarter revenue of FY23 was by far the best performing quarter of FY23 in terms of sales revenue and, as highlighted earlier, orders are continuing to increase, notably into the first quarter of FY24. Despite the sharp decrease in top line sales revenue, the reported gross margin decreased by 2.1 percentage points from 45.4% to 43.3% due to the relatively resilient performance of the proprietary prismatic product lines.

 

The EBITDA loss for the year to 30 June 2023 was a loss of A$3.9 million (2022: loss of A$2.8 million), with the main variances being the gross margin shortfall (A$1.0 million) due to the lower than estimated revenue and the costs associated with the changeover of CEO (A$0.9 million), which was offset by lower legal expenses (A$1.5 million). When adjusted for these one-off factors, the like for like comparison is an adjusted EBITDA loss of A$1.3 million (2022: loss of A$0.5 million). These results reflect the past and we believe that CAP-XX is through the worst and recovering from the revenue shortfall experienced during 2022/23.

 

Whilst our FY2023 results are disappointing, we have numerous reasons to believe that CAP-XX is turning around under Lars Stegmann's leadership. Paramount in this is the strong team of employees we have who have embraced and are contributing to the changes that are needed to enable CAP-XX to perform well for its customers and shareholders while meeting or exceeding the necessary standards of ESG. We are indebted to all of our staff.

 

The Board is confident that with the increased focus on the customer, new distribution strategy and appointment of new sales representatives, will drive the increase in sales required for the Company to achieve its positive EBITDA goal in the shortest possible time frame.

 

 

 

 

 

 

Patrick Elliott

Chairman

 

29 September 2023

 

 

Business Review

Review of Operations and Activities

 

The reported EBITDA loss for the year to 30 June 2023 was a loss of A$3.9 million (2022: loss of A$2.8 million), with the main variances being the gross margin shortfall (A$1.0 million) due to the lower than estimated revenue and the costs associated with the changeover of CEO ($0.9 million), which was offset by lower legal expenses (A$1.5m). When adjusted for these one-off factors, the like for like comparison is an adjusted EBITDA loss of A$1.3 million (2022: loss of A$0.5 million).

 

Cash reserves as at 30 June 2023 were A$2.6 million, up from A$1.6 million as at 30 June 2022. The increase in cash reserves is the direct result of the £2.7 million gross proceeds of the capital raise that was completed in early June 2023. In addition, the Board anticipates that the Company will be in receipt of a Federal Government R&D tax rebate of approximately A$2.1 million, with these funds expected to be received before the end of the current calendar year, of which A$1.0 million has been drawn down against a revolving line of credit secured by the R&D tax rebate.

 

The Company is undertaking a full evaluation of the way it analyses and reports its sales pipeline in order to ensure that all nominated opportunities are rigorously evaluated and to ensure a realistic probability of conversion of the orderbook to firm schedules within the short to medium term. This process will be completed before the end of the current calendar year. The current level of committed orders outstanding totals US$1.4 million, which is up 75% on the same time last year. Historically, CAP-XX received blanket orders, which covered the customer's next 12 months scheduled demand. Over the past two years, customers ordering patterns have changed, mainly as a result of overstocking and overall supply chain issues. Today, customers are typically only willing to provide firm orders which cover the following three months, and it is now uncommon to receive orders which cover a full 12 months. As a result, the orders outstanding are predominately for customer delivery during the period ending December 2023. Sales representatives are reporting that the overstocking issue in the supercapacitor markets are easing, and there is increasing confidence that demand and market confidence is beginning to return.

 

Total product sales revenue for the year to 30 June 2023 was A$3.3 million (2022: A$5.1 million) which represents a 35% year-on-year decrease. This follows a 44% increase in year-on-year product sales in the previous year. The contributing factors underlying this decrease, as highlighted previously, include the worldwide supply chain issues in the capacitor market, overstocking from previous years by distributors and customers, and a lack of short-term confidence in the electronic component market.

 

Operational expenditure, excluding the legal costs for patent infringement and direct costs of the Murata project, increased by 15% from A$6.3 million to A$7.2 million. The increase in expenditure is primarily attributable to the costs associated with the change in CEO.

 

Business Environment

 

The Board believes that CAP-XX's technology provides a significant competitive advantage over existing supercapacitor manufacturers such as TDK Corporation, Skeleton, Eaton, LSMitron, Nippon Chemicon Corporation and other Chinese and Korean competitors. The Board believes that these companies are unable to match the CAP-XX technology in terms of thinness, power density, energy density and reliability. Most of the Company's competitors only manufacture higher-capacity cylindrical cells used in large package modules and focus on applications where the combination of thinness, energy density and power density are not important considerations for the customer. These competitor products usually prove unsuitable for the various markets collectively labelled the Internet of Things (IoT) market, which is the key area that CAP-XX is targeting with the former Murata products and CAP-XX's existing prismatic products.

 

As reported previously, IoT applications, one of the fastest growing segments of the electronics market, provide one of the greatest opportunities for CAP-XX's products. Driven by customer requests, manufacturers are constantly moving to new wireless protocols and adding to the functions and applications available on IoT enabled devices. Some of these new functions require high electrical power within the actual IoT device. Examples are e-locks, drug dispensing, facial recognition, and haptic feedback. Other devices are powered by energy harvesting and are battery-less. Others use low power batteries such as 3 Volt coin cell batteries. All of this means that power management continues to be an increasingly important consideration. The other important factor is size, as devices have tended to become smaller whilst their electrical power demands have increased. The Company continues to be successful in winning new business from a range of these markets, such as industrial actuators, e-locks, agricultural sensors, wireless displays, smart-meters, payment and handheld terminals, medical wearables, automotive dashcams and communication systems.

 

In the past, CAP-XX has faced competition in various markets from cheaper cylindrical supercapacitors where our thin form factor, high power and long life are not valued as highly as lower initial cost components from competitors. To counteract this, the Company released a range of cylindrical cells. Modest sales revenue for these products was first recorded during FY 2019. Since then, sales have continued to grow strongly, with the Company being successful in winning a number of large volume orders, with large volume opportunities currently being evaluated by customers.

 

As previously reported, automotive applications such as TruckStart, Stop-Start systems, regenerative energy capture or KERS (Kinetic Energy Recovery Systems), distributed power, hybrid electric vehicles and electric vehicles still present substantial opportunities for large supercapacitors. A number of CAP-XX's competitors are active in these markets, and the Board believes that the Company has significant advantages over the competition in certain applications. Consistent with this strategy the Board took the opportunity to sign an exclusive distribution agreement with an established external partner who have a suite of qualified automotive products ready to market. These products are private label of CAP-XX and are known as CAPMOD and TruckStart. CAPMOD is a range of large high voltage modules intended to support a multitude of large automotive, transportation and renewable energy applications such as wind farms, solar installations. TruckStart is a relaunched version of our previous truck-start product.

 

During the year we also launched a new range of Lithium-ion supercapacitors which are a hybrid device part lithium ion and part supercapacitor, that have excellent cycle life and very low leakage current. This make these products an attractive alternative to lithium ion batteries are used where high power and long life are needed.

 

Opportunities

 

Our customers' markets are constantly evolving as new products and technologies threaten the incumbents. In this environment, CAP-XX needs to always remain alert and be flexible to changing business conditions and market needs. This creates opportunities to offer products that address what our markets want.

 

CAP-XX is continuing to refine the products that it offers for the various IoT applications and other markets. The Company has introduced its DMF and DMT thin prismatic supercapacitors to address the space-constrained and/or power-hungry needs of many IoT products. These products are already being shipped from the Company's Seven Hills factory. The Company plans to commission and commence shipments of the very thin DMH supercapacitor around Q4 2023. At only 400 microns in thickness, the Board believes that this is the best performing supercapacitor in its class. Customers are already evaluating these parts with pleasing results and large volume orders are expected in the forthcoming months.

 

The Company also plans to use its 3 Volt chemistry in the DMF products made at Seven Hills. The Company had previously planned to produce 3 Volt products in Malaysia but the ongoing disruptions and travel restrictions caused by COVID made this impractical. The first 3 Volt products from Seven Hills have been sent to customers for evaluation. The development of the 3 Volt product has been targeted to meet demand for small, inexpensive, energy efficient power solutions for thin wearables, key FOBs and other IoT devices, especially those using 3 Volt coin cell lithium ion batteries, such as the CR2032 battery.

 

In the future, there is an opportunity to migrate this same 3 Volt technology into larger prismatic supercapacitors, automotive modules, and other products for high-energy, high-power applications. As already noted, CAP-XX is concentrating on a small number of automotive opportunities. To further increase the Company's likelihood of success, the Board is investigating a strategy of partnering with automotive and military Tier-1/Tier-2 suppliers, through either a new license agreement or a joint venture, to supply the automotive markets. The Board believes that such partnerships will be beneficial for all parties involved.

 

The Company intends to continue using its intellectual property to develop additional substantial and recurring income. A significant benefit of the existing licencing agreements is that they validate CAP-XX's technology leadership in the field of supercapacitors and energy storage, and the potential for supercapacitors as a mainstream consumer electronics technology. Our licensees' product lines and sales activities are also increasing our exposure to markets and customers that were previously beyond the Company's reach. It is also important to note that the strategy of our licensees is to offer product ranges targeted at certain end markets. As such, none of them meet the product type or size requirements for all markets and all applications, leaving scope for CAP-XX to supply these other markets directly using products made by CAP-XX and its contract manufacturers.

 

 

Strategies for Growth

 

Given the high level of market interest in CAP-XX's technology and its high-performance supercapacitors, the Company believes that the IoT markets, in particular, offer significant opportunities for growth and to reach the key strategic objective of CAP-XX achieving profitability and positive cashflow.

 

The Company continues to engage in discussions aimed at securing business in the IoT space with a significant number of global original equipment manufacturers (OEMs). CAP-XX is strengthening its relationships with these organisations and has regular engineering meetings with design teams, manufacturing groups and contract manufacturers. The Company is unable to comment on specific clients, but the Board is pleased with the overall progress and is confident that the available market for supercapacitors is increasing as manufacturers become more familiar with the technology.

 

Over the last year, the Company has aligned its marketing activities to specifically focus on a number of different IoT markets, such as asset tracking, automotive, e-locks, medical devices, handheld terminals, smart meters, wearables and wireless sensors. The efforts to date have produced a significant increase in visits to the Company's webpages and sales enquiries. The Board expects this growth to continue. CAP-XX's strong environmental credentials, which have been recognised by the London Stock Exchange providing the Company with its Green Economy Mark, are consistent with this strategy.

 

The Company will continue to monitor new opportunities to increase its sales, through its current distributors, via direct sales to customers and new product offerings. These offerings may take the form of complementary energy storage devices and modules. The Company is also increasing the size of its own sales force and adding new distributors to ensure that global coverage and penetration is maximised.

 

It is important that the Company is able to benefit from the large investment made over many years in building its patent portfolio. Where third parties are found to be infringing these patent rights, the Company has and will continue to vigorously defend its rights, even if this means pursuing legal action as it did successfully against Ioxus. 

 

Research and Development

 

The markets in which the Company operates are competitive and are characterised by rapid technological change. CAP-XX has a strong competitive position in prismatic supercapacitors in all of its target markets as a result of its capability to produce supercapacitors with a high energy and power density in a small, conveniently sized, flat package. CAP-XX's devices are also lightweight, work over a broad temperature range and have an operating lifetime measured in years.

 

To stay ahead of the competition, the Company is developing a strong pipeline of new products to follow the DMH and 3 Volt products already discussed. CAP-XX's R&D efforts are focused on a mix of short, medium and long-term opportunities, covering new products, cost reductions and improved product performance. CAP-XX has a research facility within its Seven Hills site in Sydney, Australia, where a team of six scientists work to maintain CAP-XX's leading technology position in electrodes, separators and electrolyte materials and their assembly into supercapacitor devices. This team is supported by 11 engineers. During 2023, significant progress has been made in a number of key areas including improvements on the former coating, DMF and DMT lines, new cell chemistries, improving the life of cells, developing new packaging concepts, reducing the cost per cell and developing new electronics to optimise the performance of the Company's modules. CAP-XX has also signed numerous collaboration agreements with leading research institutions, whilst the Company's Scientific Advisory Board provides CAP-XX with clear direction on commercially relevant technologies for its ongoing R&D programme.

 

The Company's success depends on its ability to protect and prevent any infringements of its intellectual property. To protect this important asset, the Company has considerable intellectual property embodied in its patents covering the design, manufacture and use of its high-performance supercapacitors. The CAP-XX patent portfolio currently consists of seven patent families, with seven granted national patents with an additional two patent applications pending in various jurisdictions. The Company's intellectual property strategy has been to build value by focusing on opportunities to capture market share and exclude competition, with an IP portfolio capable of generating licensing revenue. The Directors believe that comprehensive embodiments and interlocking patent groups, combined with a 'quick to file, quick to abandon' policy, have given the Company a strong and focused IP portfolio.

 

Outlook

 

The major focus for CAP-XX continues to be to become profitable and cashflow positive as soon as possible. This will be achieved by increasing product sales from the newly installed facilities at Seven Hills, through an increased focus on the customer, new distribution strategy and expansion of the sales force, supplemented by the newly launched product families and the intellectual property which the Company is continuously developing.

 

 

CAP-XX Limited

Consolidated statement of profit or loss

For the year ended 30 June 2023

 

Consolidated

 

 

 

2023

 

2022

 

Currency: Australian Dollars

Notes

$

$

Revenue from continuing operations

1

3,631,690

5,557,260

Cost of sales

2

(2,060,527)

(3,032,921)

Gross Profit

1,571,163

2,524,339

Other revenue

1

664

3,894

Other income

3

2,165,429

2,272,442

 

General and administrative expenses

(4,264,901)

(4,478,616)

Process and engineering expenses

(1,357,516)

(1,222,409)

Selling and marketing expenses

(846,536)

(886,494)

Research and development expenses

(1,677,478)

(1,572,421)

Share based payments expense

(613,980)

(1,133,399)

Other expenses

4

(535,972)

(446,196)

Loss before income tax

(5,559,127)

(4,938,860)

Income tax benefit

-

-

Net loss for the year

(5,559,127)

(4,938,860)

 

 

Loss attributable to owners of CAP-XX Limited

(5,559,127)

(4,938,860)

 

 

Earnings per share for loss attributable to the ordinary equity holders of the Company

Cents

Cents

 

Basic loss per share

5

(1.1)

(1.0)

 

Diluted loss per share

5

(1.1)

(1.0)

 

 

 

 

CAP-XX Limited

Consolidated statement of comprehensive income

For the year ended 30 June 2023

 

Consolidated

 

 

 

2023

 

2022

 

 

Currency: Australian Dollars

Notes

$

$

 

Loss for the year

(5,559,127)

(4,938,860)

 

Other comprehensive income

 

Items that may be reclassified subsequently to profit or loss

 

 

 

Exchange differences on translation of foreign operations

(27,433)

(53,490)

 

Other comprehensive loss for the year, net of tax

(27,433)

(53,490)

 

Total comprehensive loss for the year attributable to owners of CAP-XX Limited

(5,586,560)

(4,992,350)

 

 

 

 

 

CAP-XX Limited

Consolidated statement of financial position

As at 30 June 2023

 

Consolidated

 

 

 

June 30, 2023

 

June 30, 2022

 

Currency: Australian Dollars

Notes

$

$

ASSETS

Current assets

Cash and cash equivalents

2,643,810

 1,614,714

Receivables

959,515

1,116,902

Inventories

2,201,906

1,836,148

Other

2,429,946

2,143,011

Total current assets

8,235,177

5,248,141

 

Non-current assets

 

Property, plant and equipment

2,428,233

2,696,120

Right of use assets

2,193,777

2,549,276

Other

204,808

204,808

Total non-current assets

4,826,818

5,450,204

 

Total assets

 

13,061,995

12,160,979

LIABILITIES

Current liabilities

Payables

1,833,557

1,281,367

Lease liabilities

194,888

193,261

Provisions

632,655

868,096

Interest bearing liabilities

1,038,054

-

Total current liabilities

3,699,154

2,342,724

 

Non-current liabilities

 

Lease liabilities

2,024,584

2,218,062

Provisions

803,910

757,245

Total non-current liabilities

2,828,494

2,975,307

 

Total liabilities

 

6,527,648

5,318,031

Net assets

 

6,534,347

6,842,948

 

EQUITY

Contributed equity

 119,175,769

114,511,790

Reserves

8,100,320

7,513,773

Accumulated losses

(120,741,742)

(115,182,615)

TOTAL EQUITY

 

6,534,347

6,842,948

 

 

 

 

Consolidated statement of cash flows

For the year ended 30 June 2023

 

 

Consolidated

 

 

 

2023

2022

Currency: Australian Dollars

 

$

$

Cash flows from operating activities

Receipts from customers (inclusive of goods and services tax)

3,806,845

5,122,173

Payments to suppliers and employees (inclusive of goods and services tax)

(9,976,681)

(10,604,235)

(6,169,836)

(5,482,062)

Tax credit received

2,043,384

3,200,660

Interest paid on lease liabilities

(207,787)

(290,873)

Interest received

664

3,894

Net cash (outflow) from operating activities

(4,333,575)

(2,568,381)

 

Cash flows from investing activities

 

Payments for property, plant and equipment

(118,166)

(1,89,902)

Contributions from lessor

-

163,000

Net cash (outflow) from investing activities

(118,166)

(26,902)

 

 

 

Cash flows from financing activities

 

Proceeds from issue of shares (net of costs)

5,074,950

6,106,584

Costs associated with the issue of shares

(410,971)

(456,053)

Proceeds/ (repayment) from borrowings

1,038,054

(1,400,000)

Principal repayments for lease liability

(193,763)

(169,175)

Net cash inflow from financing activities

5,508,270

4,081,356

 

Net increase in cash and cash equivalents

1,056,529

1,486,073

Cash and cash equivalents at the beginning of the financial year

1,614,714

182,601

Effects of exchange rate changes on cash and cash equivalents

(27,433)

 (53,960)

Cash and cash equivalents at the end of the financial year

 

 

2,643,810

1,614,714

 

Notes to the financial statements

 

Basis of preparation

The financial information included in this announcement does not constitute statutory accounts within the meaning of the Australian Corporations Act 2001. Whilst the financial information has been computed in accordance with Australian equivalents to International Financial Reporting standards and other authoritative pronouncements of the Australian Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001, this announcement does not itself contain sufficient information to comply with those requirements.

 

 

 

Note 1 Revenue

 

Consolidated

 

2023

2022

 

$

$

 

Sale of Goods

3,288,692

5,069,186

License Fees & Royalties

342,998

488,074

3,631,690

5,557,260

 

Other revenue

 

Interest

664

3,894

 

664

3,894

 

 

Note 2 Cost of Sale of Goods

Consolidated

 

 

2023

 

2022

 

 

$

$

 

Direct materials and labour

1,786,716

2,685,204

Indirect manufacturing expenses

273,811

347,717

2,060,527

3,032,921

 

 

 

Note 3 Other income

 

Consolidated

2023

2022

$

$

Foreign Exchange Gains - (net)

R&D Tax Incentive

22,045

2,143,384

199,308

2,073,134

2,165,429

2,272,442

 

Note 4 Other Expenses

Consolidated

 

2023

2022

 

$

$

 

 

 

 

Provision for Withholding Tax Diminution

18,274

31,268

Provision for expected credit loss

189,491 

120,484

Provision for make good on premises

40,999

-

Interest - lease liabilities

206,663

225,151

Interest - R&D Advance

80,545

69,293

535,972

446,196

 

Note 5 Loss per share

 

 

 

Consolidated

 

 

 

2023

 

2022

 

 

 

 

$

$

 

 

 

Net loss

(5,559,127)

(4,938,860)

 

Loss per share - undiluted

 

($0.011)

($0.010)

 

 

Weighted Average Shares in Issue during the year

 

529,010,650

502,535,625

 

Note 6 AASB16 Reconciliation

 

 

 

Consolidated

 

 

 

2023

 

2022

 

 

 

 

$

$

 

 

 

Balance from previous year

2,411,323

2,580,498

Additions

 

-

-

Interest on lease liabilities

 

206,663

221,580

Repayments on lease liabilities

 

(398,514)

(390,755)

Balance as at 30 June 2023

 

2,219,472

2,411,323

 

 

Note 7 EBITDA Calculation

Consolidated

2023

 

2022

 

$

$

Net loss - Reported

(5,559,127)

(4,938,860)

Depreciation

741,552

726,155

Interest Expense

328,207

294,444

Share Based payments

  613,980

1,133,399

Interest Income

(664)

(3,894)

 

EBITDA

(3,876,052)

(2,788,756)

 

 

Bad Debt Provision

189,491

-

Patent Infringement expense

1,472,664

2,388,322

CEO Transition

872,122

 

Adjusted EBITDA

 

 

 

 

(1,341,775)

 

 

 

(450,434)

 

 

 

 

 

Note 8 - Share Options Grant - CEO

 

 

The 20,000,000 share options that were granted to Lars Stegmann, Chief Executive Officer, on the 11 May 2023 and originally announced on 12 May 2023 disclosed an incorrect vesting period. The correct vesting period for Mr Stegmann's options are as follows:

· 25% will vest 24 months after the vesting commencement date.

· 6.25% of the total options shall vest on each subsequent quarterly anniversary of the vesting commencement date thereafter.

 

All other terms remain the same as announced on 12 May 2023.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UWVWRORUKUAR
Date   Source Headline
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer
8th Jun 20238:38 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSHolding(s) in Company
6th Jun 202311:38 amRNSHolding(s) in Company
2nd Jun 20238:36 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.